Hovione - Delivering Solutions, Every Breath of the Way.
Hovione is a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering for drug substance to drug product intermediate and drug product. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle.
Complete One-Site Solution for Inhalation and Nasal
Hovione offers a complete range of services, from API, formulation development and devices. Through our proven expertise and leadership in particle engineering, Hovione ensures that your inhalation and nasal therapies are engineered for success from start to finish.
Contact our experts today: hello@hovione.com
Hovione
Quinta de Sao Pedro
Sete Casas, Loures 2674-506
Portugal
+351 21 982 9000
www.hovione.com
hello@hovione.com
Hovione—Delivering Solutions, Every Breath of the Way
Hovione offers customized high-performance APIs, particle engineering and formulation along with a full range of highly specialized, patented and innovative devices, all in one site. Through our proven expertise and leadership in particle engineering, we ensure that your inhalation and nasal therapies are engineered for success from start to finish. More Info
Hovione—Inhalation and Nasal Journey
Hovione offers a One-Site Solution for Inhalation and Nasal. Our inhalation grade APIs bring unique controlled performance to your formulation and our recognized leadership in particle engineering - an essential technology for developing inhalation drug products - ensures that you benefit from our dedication to Quality by Design principles. At Hovione we are fully equipped to meet your device needs with our integrated filling services.
More Info
Hovione—Expanding Nasal Drug Delivery Capabilities
Hovione and Industrial Design Consultancy (IDC) have entered into a joint development of an innovative nasal powder delivery device technology supporting local, systemic, and nose-to-brain drug delivery.
Nasal delivery is a simple and safe alternative to conventional delivery routes for drug delivery, which offers a faster onset of action. It is also seen as a promising pathway to deliver new drugs to the brain and treat diseases of the central nervous system.
More Info
Hovione—Innovative Dry Powder Inhalers (DPIs)
Hovione offering includes simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.
These devices address various applications like asthma, COPD, and more. Each inhaler design focuses on ease of use and cost-effectiveness, aimed at delivering high-quality inhalation medicines to patients worldwide.
More Info
Hovione—On-demand Webinar: Nasal Powder Delivery: Process, Formulation and Analytical Characterization
Join Hovione’s webinar to receive valuable insights on the process of nasal powder delivery, addressing current gaps in formulation, particle engineering, and nasal absorption.
The session will cover diverse formulation platforms, focusing on poorly soluble drugs, and aligning pharmacokinetic requirements with therapeutic goals.
More Info
Hovione—On-Demand Webinar: High Performance Solutions for DPI Delivery: New Formulation and Device Platforms
This webinar will focus on advanced solutions for dry powder inhaler (DPI) development, including novel formulation and device platforms, and analytical characterization.
Participants will learn about maximizing drug delivery efficiency for high-dose medications, exploring milling capabilities for fine particle doses, and understanding aerodynamic performance through analytical techniques.
More Info
